At the news
? NEUTRALIMPACT 2/10 8-K filed Jun 26, 2026 at 15:45 ET
Stryker filed an 8-K to recast historical segment financials for 2023-2025 following a Q1 2026 organizational restructuring that created a new Ortho Tech business (combining orthopaedic instruments with Mako/enabling technologies). This is a routine accounting change to conform prior-period segment data to the new reporting structure, it does not restate or amend the audited consolidated financial statements and contains no new financial results, guidance, or material events.
- Stryker reorganized in Q1 2026, creating a new Ortho Tech business within the Orthopaedics segment by combining orthopaedic instruments from Instruments with Mako and enabling technologies from Other Orthopaedics.
- The two reportable segments remain MedSurg and Neurotechnology and Orthopaedics.
- Historical segment financials for 2023-2025 have been recast to reflect the new structure; consolidated results are unchanged.
- The filing includes recast MD&A, financial statements, and notes from the 2025 10-K, plus an auditor consent (Exhibit 23.1).
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access